You are here: Industry Insights > Series A financing

News List

Bioelectronica Announces Hypercell™ Expansion for Antibody Discovery, Closing of Oversubscribed Series A Financing, Powering Local Hiring Growth and Expansion of Facilities in Reno prnasia
July 19, 2021
Bioelectronica® Corporation announced today that it has secured an undisclosed amount in its Series A financing round due to increased interest in Hypercell™, a new hardware tool that can be used to discover new antibodies using computer vision ...
Ronovo Surgical Completes Series A Financing, Aims to Transform Surgery with Innovations Focused on Simplicity, Precision and Intelligence. prnasia
April 26, 2021
Ronovo Surgical, an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery to address the tremendous needs of the Chinese surgical market, recently announced successful closing of Series A financing.
Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing prnasia
November 30, 2020
Eluminex Biosciences Limited announced the completion of a $50 million (USD) Series A Financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
Forge Biologics Completes Series A Financing contractpharma
August 03, 2020
The company is advancing development candidates for the treatment of Krabbe disease.
Amunix raises $73m in Series A financing led by Omega Funds pharmaceutical-business-review
March 06, 2020
Amunix Pharmaceuticals, Inc., a biopharmaceutical company focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers.
Filterlex Medical raises $3M in Series A Financing biospectrumasia
July 16, 2019
Filterlex won the best innovation award at the EuroPCR 2019 conference in Paris and was awarded $200,000 prize by the Jon DeHaan Foundation
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline biospectrumasia
July 15, 2019
The fundraiser builds upon Hummingbird's recent momentum in receiving a USD 13.1M product development grant from the CPRIT to support Phase IA/B clinical trials of its anti-VISTA antibody for the treatment of solid tumours and lymphomas
CureGenetics secures $17 M in Series A Financing biospectrumasia
August 08, 2018
The company intends to use the proceeds to further optimize its gene editing and delivery platform.
China invests $85 M in Ansun Biopharma biospectrumasia
May 16, 2018
Ansun plans to use the proceeds from the Series A to fund a Phase 3 clinical trial of its experimental anti-viral medication, DAS181.
Inthera Bioscience Raises CHF 10.5 Million in Series A Financing Round b3cnewswire
June 01, 2017
Inthera Bioscience, a Swiss biopharmaceutical company developing first-in-class targeted small molecule therapies for solid tumors, today announced the closing of a Series A financing of CHF 10.5 million (EUR 9.6 million).

Previous page 1 2 Next page